Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
The current price of Pfizer Inc in the market is 1Β 970,83Β β½, with a 24-hour trading volume of 1,18BΒ β½. The asset's market cap is 11,2TΒ β½, after moving -0.18% in the last day.
Tokenized Pfizer Inc is trading at 1Β 989,67Β β½, with a tokenized market cap of 326,65MΒ β½ and a 24-hour trading volume of 104,87KΒ β½. The tokenized asset has moved -0.11% in the past 24 hours.